AU2292800A - Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies - Google Patents

Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies

Info

Publication number
AU2292800A
AU2292800A AU22928/00A AU2292800A AU2292800A AU 2292800 A AU2292800 A AU 2292800A AU 22928/00 A AU22928/00 A AU 22928/00A AU 2292800 A AU2292800 A AU 2292800A AU 2292800 A AU2292800 A AU 2292800A
Authority
AU
Australia
Prior art keywords
andprotective
antibodies
neisseria meningitidis
antigenic polypeptides
corresponding polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22928/00A
Other languages
English (en)
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9901465.6A external-priority patent/GB9901465D0/en
Priority claimed from GBGB9902077.8A external-priority patent/GB9902077D0/en
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2292800A publication Critical patent/AU2292800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/22—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Neisseriaceae (F), e.g. Acinetobacter
AU22928/00A 1999-01-22 2000-01-19 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies Abandoned AU2292800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9901465.6A GB9901465D0 (en) 1999-01-22 1999-01-22 Novel compounds
GB9901465 1999-01-22
GBGB9902077.8A GB9902077D0 (en) 1999-01-29 1999-01-29 Novel compounds
GB9902077 1999-01-29
PCT/EP2000/000427 WO2000043518A1 (fr) 1999-01-22 2000-01-19 Polypeptides antigeniques de neisseria meningitidis, polynucleotides correspondants et anticorps protecteurs

Publications (1)

Publication Number Publication Date
AU2292800A true AU2292800A (en) 2000-08-07

Family

ID=26315022

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22928/00A Abandoned AU2292800A (en) 1999-01-22 2000-01-19 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies

Country Status (4)

Country Link
EP (1) EP1147194A1 (fr)
AU (1) AU2292800A (fr)
CA (1) CA2360658A1 (fr)
WO (1) WO2000043518A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02004283A (es) 1999-10-29 2002-10-17 Chiron Spa Peptidos antigenicos neisseriales.
CN1800385B (zh) 2000-02-28 2010-06-02 启龙有限公司 奈瑟球菌蛋白质的异源表达
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
HUE052850T2 (hu) 2010-08-23 2021-05-28 Wyeth Llc Neisseria meningitidis RLP2086 antigéneket tartalmazó stabil készítmények
NZ607224A (en) 2010-09-10 2014-11-28 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
RU2014135522A (ru) 2012-02-02 2016-03-27 Новартис Аг Промоторы для увеличенной экспрессии белка у менингококка
KR101763625B1 (ko) 2012-03-09 2017-08-01 화이자 인코포레이티드 수막염균 조성물 및 이의 사용 방법
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
ES2685894T3 (es) 2013-03-08 2018-10-15 Pfizer Inc. Polipéptidos de fusión inmunogénicos
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
EP3270959A1 (fr) 2015-02-19 2018-01-24 Pfizer Inc Compositions de neisseria meningitidis et méthodes associées
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
NZ508366A (en) * 1998-05-01 2004-03-26 Chiron Corp Neisseria meningitidis antigens and compositions

Also Published As

Publication number Publication date
EP1147194A1 (fr) 2001-10-24
CA2360658A1 (fr) 2000-07-27
WO2000043518A1 (fr) 2000-07-27

Similar Documents

Publication Publication Date Title
PT1801219E (pt) Péptidos antigénicos de neisseria
AU4802500A (en) 2-aminoquinolinecarboxamides: neurokinin receptor ligands
AU2001233156A1 (en) Bcl-2-like polynucleotides, polypeptides, and antibodies
AU7445900A (en) Novel hemopoietin receptor protein, nr12
MXPA02012045A (es) Nuevos derivados de oxazolidinona y proceso para su preparacion.
AU5805500A (en) A method for preparing modified polypeptides
AU1191001A (en) Plasminogen-like polynucleotides, polypeptides, and antibodies
AU3075801A (en) Transferrin polynucleotides, polypeptides, and antibodies
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
AU2292800A (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides andprotective antibodies
AU7337400A (en) B7-like polynucleotides, polypeptides, and antibodies
AU2001253323A1 (en) Extracellular matrix polynucleotides, polypeptides, and antibodies
AU1582401A (en) Uteroglobin-like polynucleotides, polypeptides, and antibodies
AU2289000A (en) (neisseria meningitidis) polypeptide basb052
AU7335400A (en) Attractin-like polynucleotides, polypeptides, and antibodies
EP1222253A4 (fr) Polynucleotides, polypeptides et anticorps interagissant avec les recepteurs de retinoides
AU7056100A (en) Tgf-beta receptor polynucleotides, polypeptides, and antibodies
AU2002353764A1 (en) Staphylococci surface-exposed immunogenic polypeptides
AU4781100A (en) Ip3 receptor ligands
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
EP1189944A4 (fr) Axor16, r cepteur coupl une prot ine g
IL149507A0 (en) 3-(4,5-dihydroisoxazole-5-yl) benzoylpyrazole
HK1042725A1 (zh) 腦膜炎球菌多肽
HK1043151A1 (zh) 奈瑟菌腦膜炎抗原多肽，相應的聚核苷酸和保護抗體
AU2107400A (en) Neisseria meningitidis antigen

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase